Flumist Related Clinical Trials
Safety Study of FluMist With and Without Ampligen [Recruiting]
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza [Completed]
A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults [Completed]
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Completed]
FluMist in Egg Allergic Patients [Recruiting]
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season [Recruiting]
School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities [Completed]
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program [Active, not recruiting]
A Phase 2 Study to Evaluate Immune Responses of FluMist® [Completed]
Evaluating Immune Response to Seasonal FluMist in Healthy Adults [Terminated]
Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects [Completed]
Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM [Completed]
A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age [Completed]
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021)- Year 1, 2011 [Active, not recruiting]
A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 [Completed]
Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults [Completed]
Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years [Completed]
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects [Completed]
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age [Completed]
Study of Quadrivalent Influenza Vaccine Among Adults [Completed]
A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults [Completed]
2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women [Completed]
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers [Recruiting]
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects [Completed]
Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants [Terminated]
Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. [Completed]
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households [Completed]
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults [Completed]
Safety Study to Evaluate FluMist in Immunocompromised Children [Completed]
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 [Active, not recruiting]
A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age [Completed]
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study [Completed]
Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years [Completed]
Home Administration of FluMist by Parents/Caregivers [Active, not recruiting]
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children [Completed]
A Study of a Live Intranasal Influenza Vaccine in Children With Cancer [Completed]
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy [Active, not recruiting]
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine [Active, not recruiting]
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children [Completed]
Evaluate Reactogenicity and Immunogenicity of Standard-dose (SD) Versus High-dose (HD) Inactivated Influenza Vaccine Trivalent (IIV3) in Recipients of Solid Organ Transplants. [Recruiting]
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine [Completed]
Direct and Indirect Protection by Influenza Vaccine Given to Children in India [Completed]
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) [Active, not recruiting]
Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant [Completed]
Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents [Enrolling by invitation]
Influenza Vaccine in Pregnant Women [Completed]
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age [Completed]
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults [Completed]
Assessing Choice in the Employer Setting (ACES) Study [Completed]
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects [Completed]
Proteomic Profiling for Influenza Vaccination - FluMist [Completed]
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting [Completed]
A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. [Completed]
Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents [Completed]
Trial to Collect Safety Data and Sera for Immunogenicity Testing [Completed]
A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children [Completed]
Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal [Completed]
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A [Completed]
A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist [Completed]
Brief Influenza Vaccine Education to Pregnant Women [Active, not recruiting]
Maternal Flu Vaccine Trial in Bamako, Mali [Active, not recruiting]
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix [Completed]
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older [Completed]
Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus [Completed]
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program [Completed]
Self-Administered Nasal Influenza Feasibility Study [Completed]
Seasonal Influenza Vaccine Effectiveness Study in Kenya [Recruiting]
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV [Completed]
Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children [Completed]
Field Trial of Maternal Influenza Immunization in Asia [Recruiting]
Impact of Influenza Vaccination in Pregnancy Video Education [Completed]
Influenza Vaccine in HIV Infected Children [Completed]
Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects [Completed]
Influenza Immunization of Children in India [Active, not recruiting]
The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis [Recruiting]
A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly [Completed]
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above [Completed]
Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A) [Completed]
A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults [Completed]
Immune Responses to the Flu Shot During Pregnancy [Recruiting]
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine [Completed]
|
